Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Behav Pharmacol ; 34(5): 299-305, 2023 08 01.
Article in English | MEDLINE | ID: mdl-37401404

ABSTRACT

The growing usage of aluminum nanoparticles (Al-NP) and their exposure may influence body function. Considering the proposed relationship between Al and the pathogenesis of Alzheimer's disease and the concern about the effect of this nanoparticle on brain health and cognitive function, the use of neuroprotective agents might be helpful. According to the reported neuroprotective effects of agmatine, in the present study, the possible protective effect of agmatine was assessed in mice model of Al-NP-induced memory impairment. In addition, due to the roles of hippocampal Glycogen synthase kinase-3 beta (GSK-3ß) and ERK signaling in memory and its disorders, these pathways were also investigated. Al-NP (10 mg/kg/p.o.) with/without agmatine (5 or 10 mg/kg/i.p.) was administered to adult male NMRI mice for 5 days. Novel object recognition (NOR) test session was used to assess cognitive function. Following the behavioral assessments, the hippocampi were used to determine the phosphorylated and total levels of GSK-3ß and ERK as well as GAPDH using western blot analysis. The results showed that Al-NP impaired NOR memory in mice while agmatine 10 mg/kg prevented the memory deficit induced by Al-NP. Furthermore, Al-NP activated GSK-3ß as well as ERK signals within the hippocampus while agmatine prevented the effects of Al-NP on GSK-3ß and ERK signals within the hippocampus. Besides supporting the neuroprotective effects of agmatine, these findings suggest the possibility of the connection of hippocampal GSK-3ß and ERK signaling in the neuroprotective effect of this polyamine against Al-NP.


Subject(s)
Agmatine , Neuroprotective Agents , Mice , Male , Animals , Agmatine/pharmacology , Aluminum/toxicity , Aluminum/metabolism , Glycogen Synthase Kinase 3 beta/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Neuroprotective Agents/pharmacology , Memory Disorders/chemically induced , Memory Disorders/drug therapy , Memory Disorders/prevention & control , Hippocampus
2.
Nanomaterials (Basel) ; 10(5)2020 May 18.
Article in English | MEDLINE | ID: mdl-32443641

ABSTRACT

As a fixed reservoir rock property, pore throat size distribution (PSD) is known to affect the distribution of reservoir fluid saturation strongly. This study aims to investigate the relations between the PSD and the oil-water relative permeabilities of reservoir rock with a focus on the efficiency of surfactant-nanofluid flooding as an enhanced oil recovery (EOR) technique. For this purpose, mercury injection capillary pressure (MICP) tests were conducted on two core plugs with similar rock types (in respect to their flow zone index (FZI) values), which were selected among more than 20 core plugs, to examine the effectiveness of a surfactant-nanoparticle EOR method for reducing the amount of oil left behind after secondary core flooding experiments. Thus, interfacial tension (IFT) and contact angle measurements were carried out to determine the optimum concentrations of an anionic surfactant and silica nanoparticles (NPs) for core flooding experiments. Results of relative permeability tests showed that the PSDs could significantly affect the endpoints of the relative permeability curves, and a large amount of unswept oil could be recovered by flooding a mixture of the alpha olefin sulfonate (AOS) surfactant + silica NPs as an EOR solution. Results of core flooding tests indicated that the injection of AOS + NPs solution in tertiary mode could increase the post-water flooding oil recovery by up to 2.5% and 8.6% for the carbonate core plugs with homogeneous and heterogeneous PSDs, respectively.

3.
J Gastrointest Cancer ; 46(2): 138-42, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25761643

ABSTRACT

PURPOSE: The aim of this paper is to study urinary5-hydroxyindoleacetic acid (5-HIAA) in gastric cancer patients with a biochemical method and compare this metabolite with normal control and individuals with chronic gastritis. MATERIALS AND METHODS: The subjects were 48 histologically proven gastric adenocarcinoma patients. They were 10 women and 38 men with mean age of 63.73 years. For determination of urinary excretion of 5-HIAA, a biochemical method was applied. According to kit protocol, the patients' fresh urine was added to the reagent material, and the color of the sediment that was the result of interaction between 5-HIAA and the mercury salt was compared with the standard colorimetric plate of the kit. The same method was also performed for a group of 47 patients with chronic gastritis and also a group of 50 normal individuals (age and sex matched). RESULTS: Urinary 5-HIAA was significantly higher in gastric cancer patients compared to individuals with chronic gastritis and normal controls (P value <0.001), but no association was detected in urinary 5-HIAA based on age, sex, or site of tumor and tumor grade in gastric cancer patients group. Also, no significant difference was noted in 5-HIAA excretion between chronic gastritis and normal control groups. CONCLUSION: Urinary excretion of 5-HIAA is significantly higher in the gastric cancer patients in comparison with that of chronic gastritis patients or normal individuals. So, this test could be regarded as a tumor marker in conjunction with other modalities in diagnosis of gastric cancer.


Subject(s)
Biomarkers, Tumor/urine , Gastric Mucosa/metabolism , Hydroxyindoleacetic Acid/urine , Metabolomics , Stomach Neoplasms/urine , Aged , Case-Control Studies , Female , Follow-Up Studies , Humans , Male , Middle Aged , Neoplasm Grading , Prognosis , Stomach Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...